GB201916084D0 - 1-acetyl-5-nitro-4-phenyl-3-pyrrolin-2-one for use in cancer treatment - Google Patents
1-acetyl-5-nitro-4-phenyl-3-pyrrolin-2-one for use in cancer treatmentInfo
- Publication number
- GB201916084D0 GB201916084D0 GBGB1916084.5A GB201916084A GB201916084D0 GB 201916084 D0 GB201916084 D0 GB 201916084D0 GB 201916084 A GB201916084 A GB 201916084A GB 201916084 D0 GB201916084 D0 GB 201916084D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- pyrrolin
- acetyl
- nitro
- phenyl
- cancer treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LVP-17-51A LV15384B (en) | 2017-07-24 | 2017-07-24 | 1-acetyl-5-nitro-4-phenyl-3-pyrrolin-2-one for use in the treatment of cancer |
PCT/IB2018/051917 WO2019021067A1 (en) | 2017-07-24 | 2018-03-22 | 1-acetyl-5-nitro-4-phenyl-3-pyrrolin-2-one for use in cancer treatment |
Publications (3)
Publication Number | Publication Date |
---|---|
GB201916084D0 true GB201916084D0 (en) | 2019-12-18 |
GB2578008A GB2578008A (en) | 2020-04-15 |
GB2578008B GB2578008B (en) | 2022-03-16 |
Family
ID=59858757
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1916084.5A Active GB2578008B (en) | 2017-07-24 | 2018-03-22 | 1-Acetyl-5-Nitro-4-Phenyl-3-Pyrrolin-2-one for use in cancer treatment |
Country Status (3)
Country | Link |
---|---|
GB (1) | GB2578008B (en) |
LV (1) | LV15384B (en) |
WO (1) | WO2019021067A1 (en) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6500948B1 (en) | 1995-12-08 | 2002-12-31 | Agouron Pharmaceuticals, Inc. | Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof |
AU746853B2 (en) | 1997-06-21 | 2002-05-02 | Roche Diagnostics Gmbh | Barbituric acid derivatives with antimetastatic and antitumor activity |
WO2004037171A2 (en) * | 2002-10-18 | 2004-05-06 | Merck & Co., Inc. | Mitotic kinesin inhibitors |
ATE482956T1 (en) | 2004-07-21 | 2010-10-15 | Merck Serono Sa | OCTAHYDROPYRROLOÄ2, 3, CÜPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF |
KR100829257B1 (en) | 2006-06-22 | 2008-05-14 | 부경대학교 산학협력단 | Caboxylated glucosamine compounds for inhibiting the the activation and expression of matrix metalloproteinase-9 in human fibrosacroma cells and matrix metalloproteinase-9 inhibitors contanining the same |
-
2017
- 2017-07-24 LV LVP-17-51A patent/LV15384B/en unknown
-
2018
- 2018-03-22 GB GB1916084.5A patent/GB2578008B/en active Active
- 2018-03-22 WO PCT/IB2018/051917 patent/WO2019021067A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
GB2578008B (en) | 2022-03-16 |
WO2019021067A1 (en) | 2019-01-31 |
LV15384A (en) | 2019-02-20 |
GB2578008A (en) | 2020-04-15 |
LV15384B (en) | 2019-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267158B (en) | Amino-triazolopyridine compounds and their use in treating cancer | |
IL251630A0 (en) | Combination therapy for use in cancer therapy | |
IL282663A (en) | Bt1718 for use in treating cancer | |
IL263802A (en) | Cancer treatment combinations | |
IL251905A0 (en) | Apilimod for use in the treatment of renal cancer | |
PT3576740T (en) | Cancer treatment | |
IL251903A0 (en) | Apilimod for use in the treatment of colorectal cancer | |
GB201706451D0 (en) | Cancer treatment | |
IL262143A (en) | Improvements in cancer treatment | |
IL261648A (en) | Cinnolin-4-amine compounds and their use in treating cancer | |
IL268463A (en) | Cancer treatment | |
SG10202001388YA (en) | Use of ureidomustine (bo-1055) in cancer treatment | |
HK1251794A1 (en) | Cancer treatment | |
IL259358A (en) | Bis-pyridazine compounds and their use in treating cancer | |
IL274626A (en) | Cancer treatment | |
EP3440052C0 (en) | Compounds for use in the treatment of cancer | |
IL269121A (en) | Usl-311 for use in the treatment of cancer | |
GB201707864D0 (en) | Platinum-reistant cancer treatment | |
GB2578008B (en) | 1-Acetyl-5-Nitro-4-Phenyl-3-Pyrrolin-2-one for use in cancer treatment | |
ZA202001435B (en) | Abx196 for use in the treatment of bladder cancer | |
GB201713852D0 (en) | Cancer treatment | |
GB201510764D0 (en) | bis-Pyridazine compounds and their use in treating cancer | |
GB201411111D0 (en) | bis-Pyridazine compounds and their use in treating cancer |